Proceedings of the National Academy of Sciences · 2020 · 149 citations · 34 references
Life SciencesCell BiologyNephrologyCell SignalingRenal PathophysiologySignal TransductionFibrosisImmune SignalingMacrophage BiologyRenal DiseaseRenal FibrosisRenal ImmunopathologyFibrosis InhibitionPathogenic EffectsRenal Fibrosis MechanismsSmad Signaling PathwaySystemic TargetingTargetingTherapeutic Target IdentificationTransforming Growth Factor-beta Signaling
Unresolved inflammation can lead to tissue fibrosis and impaired organ function. Macrophage-myofibroblast transition (MMT) is one newly identified mechanism by which ongoing chronic inflammation causes progressive fibrosis in different forms of kidney disease. However, the mechanisms underlying MMT are still largely unknown. Here, we discovered a brain-specific homeobox/POU domain protein Pou4f1 (Brn3a) as a specific regulator of MMT. Interestingly, we found that Pou4f1 is highly expressed by macrophages undergoing MMT in sites of fibrosis in human and experimental kidney disease, identified by coexpression of the myofibroblast marker, α-SMA. Unexpectedly, Pou4f1 expression peaked in the early stage in renal fibrogenesis in vivo and during MMT of bone marrow-derived macrophages (BMDMs) in vitro. Mechanistically, chromatin immunoprecipitation (ChIP) assay identified that Pou4f1 is a Smad3 target and the key downstream regulator of MMT, while microarray analysis defined a Pou4f1-dependent fibrogenic gene network for promoting TGF-β1/Smad3-driven MMT in BMDMs at the transcriptional level. More importantly, using two mouse models of progressive renal interstitial fibrosis featuring the MMT process, we demonstrated that adoptive transfer of TGF-β1-stimulated BMDMs restored both MMT and renal fibrosis in macrophage-depleted mice, which was prevented by silencing Pou4f1 in transferred BMDMs. These findings establish a role for Pou4f1 in MMT and renal fibrosis and suggest that Pou4f1 may be a therapeutic target for chronic kidney disease with progressive renal fibrosis.
34
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
Elisabeth M. Zeisberg, Oleg Tarnavski, Michael Zeisberg et al. · Nature Medicine · 2007 · 2.2K citations
Medicine, Cardiology, Physiology +12
Origin and function of myofibroblasts in kidney fibrosis
Valerie S. LeBleu, Gangadhar Taduri, Joyce T. O’Connell et al. · Nature Medicine · 2013 · 1.2K citations · Full text
Medicine, Cell Biology, Nephrology +12